Lycov1404 Bebtelovimab
Contract Overview
Contract Amount: $1,463,250,000 ($1.5B)
Contractor: ELI Lilly and Company
Awarding Agency: Department of Defense
Start Date: 2022-02-10
End Date: 2023-09-30
Contract Duration: 597 days
Daily Burn Rate: $2.5M/day
Official Description: LYCOV1404 BEBTELOVIMAB
Place of Performance
Location: Indiana, 46285
State: Indiana Government Spending